FDA Issues Update on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)

Related Keywords

United States , ,Letter To Health Care Providers ,Technology Trifecta ,Drug Administration ,Health Care Providers ,Abbott Trifecta ,Trifecta Valve ,Glide Technology ,External Link Disclaimer ,Unique Device Identifier ,